Loading...
Loading...
India's erythromycin imports from BANGLADESH total $180 across 4 shipments from 1 foreign suppliers. INCEPTA PHARMACEUTICALS LIMITED leads with $180 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include RAPTIM RESEARCH PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for erythromycin — a concentrated sourcing relationship with select suppliers from BANGLADESH.

INCEPTA PHARMACEUTICALS LIMITED is the leading Erythromycin supplier from BANGLADESH to India, with import value of $180 across 4 shipments. The top 5 suppliers — INCEPTA PHARMACEUTICALS LIMITED — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | INCEPTA PHARMACEUTICALS LIMITED | $180 | 4 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | RAPTIM RESEARCH PRIVATE LIMITED | $150 | 2 | 83.3% |
| 2 | CITUS RESEARCH LLP | $30 | 2 | 16.7% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Erythromycin suppliers from BANGLADESH to India include INCEPTA PHARMACEUTICALS LIMITED. The leading supplier is INCEPTA PHARMACEUTICALS LIMITED with import value of $180 USD across 4 shipments. India imported Erythromycin worth $180 USD from BANGLADESH in total across 4 shipments.
India imported Erythromycin worth $180 USD from BANGLADESH across 4 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Erythromycin sourced from BANGLADESH include RAPTIM RESEARCH PRIVATE LIMITED, CITUS RESEARCH LLP. The largest buyer is RAPTIM RESEARCH PRIVATE LIMITED with $150 in imports across 2 shipments.
The total value of Erythromycin imports from BANGLADESH to India is $180 USD, across 4 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4 Verified Shipments
1 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists